CBP30, a selective CBP/p300 bromodomain inhibitor, suppresses human Th17 responses

Ariane Hammitzsch; Cynthia Tallant; Oleg Fedorov; Alison O’Mahony; Paul E. Brennan; Duncan A. Hay; Fernando O Martinez; M.  Hussein Al-Mossawi; Jelle de Wit; Matteo Vecellio; Christopher Wells; Paul Wordsworth; Susanne Müller; Stefan Knapp; Paul Bowness

doi:10.1073/pnas.1501956112

Back

CBP30, a selective CBP/p300 bromodomain inhibitor, suppresses human Th17 responses

Journal article

Peer reviewed

CBP30, a selective CBP/p300 bromodomain inhibitor, suppresses human Th17 responses

Ariane Hammitzsch, Cynthia Tallant, Oleg Fedorov, Alison O’Mahony, Paul E. Brennan, Duncan A. Hay, Fernando O Martinez, M. Hussein Al-Mossawi, Jelle de Wit, Matteo Vecellio, …

Proceedings of the National Academy of Sciences of the United States of America

25/08/2015

DOI: https://doi.org/10.1073/pnas.1501956112

Metrics

16 Record Views

182 Times Cited - Web of Science

See more details

Details

Title: CBP30, a selective CBP/p300 bromodomain inhibitor, suppresses human Th17 responses
Creators: Ariane Hammitzsch
Cynthia Tallant
Oleg Fedorov
Alison O’Mahony
Paul E. Brennan
Duncan A. Hay
Fernando O Martinez - University of Surrey, School of Biosciences
M. Hussein Al-Mossawi
Jelle de Wit
Matteo Vecellio
Christopher Wells
Paul Wordsworth
Susanne Müller
Stefan Knapp
Paul Bowness
Publication Details: Proceedings of the National Academy of Sciences of the United States of America
Date published: 25/08/2015
Identifiers: 99596918702346
Academic Unit: School of Biosciences
Resource Type: Journal article

CBP30, a selective CBP/p300 bromodomain inhibitor, suppresses human Th17 responses

Metrics

Details

Usage Policy